Literature DB >> 11924738

Support Vector Machines for predicting HIV protease cleavage sites in protein.

Yu-Dong Cai1, Xiao-Jun Liu, Xue-Biao Xu, Kuo-Chen Chou.   

Abstract

Knowledge of the polyprotein cleavage sites by HIV protease will refine our understanding of its specificity, and the information thus acquired is useful for designing specific and efficient HIV protease inhibitors. The pace in searching for the proper inhibitors of HIV protease will be greatly expedited if one can find an accurate, robust, and rapid method for predicting the cleavage sites in proteins by HIV protease. In this article, a Support Vector Machine is applied to predict the cleavability of oligopeptides by proteases with multiple and extended specificity subsites. We selected HIV-1 protease as the subject of the study. Two hundred ninety-nine oligopeptides were chosen for the training set, while the other 63 oligopeptides were taken as a test set. Because of its high rate of self-consistency (299/299 = 100%), a good result in the jackknife test (286/299 = 95%) and correct prediction rate (55/63 = 87%), it is expected that the Support Vector Machine method can be referred to as a useful assistant technique for finding effective inhibitors of HIV protease, which is one of the targets in designing potential drugs against AIDS. The principle of the Support Vector Machine method can also be applied to analyzing the specificity of other multisubsite enzymes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11924738     DOI: 10.1002/jcc.10017

Source DB:  PubMed          Journal:  J Comput Chem        ISSN: 0192-8651            Impact factor:   3.376


  17 in total

1.  Prediction of RNA-binding proteins from primary sequence by a support vector machine approach.

Authors:  Lian Yi Han; Cong Zhong Cai; Siew Lin Lo; Maxey C M Chung; Yu Zong Chen
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

2.  The prediction of human oral absorption for diffusion rate-limited drugs based on heuristic method and support vector machine.

Authors:  H X Liu; R J Hu; R S Zhang; X J Yao; M C Liu; Z D Hu; B T Fan
Journal:  J Comput Aided Mol Des       Date:  2005-01       Impact factor: 3.686

3.  Prediction of interaction between small molecule and enzyme using AdaBoost.

Authors:  Bing Niu; Yuhuan Jin; Lin Lu; Kaiyan Fen; Lei Gu; Zhisong He; Wencong Lu; Yixue Li; Yudong Cai
Journal:  Mol Divers       Date:  2009-02-14       Impact factor: 2.943

4.  Predicting human immunodeficiency virus protease cleavage sites in nonlinear projection space.

Authors:  Xuehua Li; Hongli Hu; Lan Shu
Journal:  Mol Cell Biochem       Date:  2010-01-07       Impact factor: 3.396

5.  Prediction of lipid-binding sites based on support vector machine and position specific scoring matrix.

Authors:  Wenjia Xiong; Yanzhi Guo; Menglong Li
Journal:  Protein J       Date:  2010-08       Impact factor: 2.371

6.  Comprehensive bioinformatic analysis of the specificity of human immunodeficiency virus type 1 protease.

Authors:  Liwen You; Daniel Garwicz; Thorsteinn Rögnvaldsson
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Prediction of PKCθ inhibitory activity using the Random Forest Algorithm.

Authors:  Ming Hao; Yan Li; Yonghua Wang; Shuwei Zhang
Journal:  Int J Mol Sci       Date:  2010-09-20       Impact factor: 5.923

8.  Identification of amino acid propensities that are strong determinants of linear B-cell epitope using neural networks.

Authors:  Chun-Hung Su; Nikhil R Pal; Ken-Li Lin; I-Fang Chung
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

9.  SVM-based prediction of caspase substrate cleavage sites.

Authors:  Lawrence J K Wee; Tin Wee Tan; Shoba Ranganathan
Journal:  BMC Bioinformatics       Date:  2006-12-18       Impact factor: 3.169

10.  Comparison between the repression potency of siRNA targeting the coding region and the 3'-untranslated region of mRNA.

Authors:  Ching-Fang Lai; Chih-Ying Chen; Lo-Chun Au
Journal:  Biomed Res Int       Date:  2013-06-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.